Author

Allison Thompson

Nationwide Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Adam P. OstendorfiD· 1 shared Adithe RivaldiiD· 1 shared Allison Daley· 1 shared Ammar ShaikhouniiD· 1 shared Ari Zavarella· 1 shared Ashton S. HolubiD· 1 shared Christopher R. PiersoniD· 1 shared Corinne Strawser· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Adam P. OstendorfORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsy

Lauren Mashburn‐Warren, Ashton S. Holub, Sahibjot Sran, Swetha Ramadesikan, Keaton Suh, Allison Thompson, James J. Anderson, Adithe Rivaldi, Ari Zavarella, Megan Chandler, Allison Daley, Corinne Strawser, Elizabeth A.R. Garfinkle, Jonathan Pindrik, Ammar Shaikhouni, , Tracy A. Bedrosian

The paper identifies somatic RAS-MAPK pathway activating variants in hippocampal sclerosis patients, linking them to seizure-induced injury and suggesting therapeutic targets.

bioRxiv · Apr 9, 2026 · PreprintNeuroscience